Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/10839289

Download in:

View as

General Info

PMID
10839289